The Myeloproliferative Neoplasms Channel is supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
Texas MPN Workshop 2022 | CMML: unmet needs and future outlooks
In this video, Eric Padron, MD, H. Lee Moffitt Cancer Center, Tampa, FL, discusses unmet needs in chronic myelomonocytic leukemia (CMML), highlighting the need to develop therapies that modify disease and the importance of better understanding factors that lead to disease progression. This interview took place at the third annual Texas MPN Workshop (TMW) 2022, held in San Antonio, TX.
Disclosures
Research Funding: Kura, Incyte, BMS
Honoraria: Blueprint, Novartis, Stem line, Taiho, Pharmaessentia
